Genes in panel
STRs in panel
Prev Next
Regions in panel
Prev Next

White matter disorders and cerebral calcification - narrow panel

Gene: JAM2

Amber List (moderate evidence)

JAM2 (junctional adhesion molecule 2)
EnsemblGeneIds (GRCh38): ENSG00000154721
EnsemblGeneIds (GRCh37): ENSG00000154721
OMIM: 606870, Gene2Phenotype
JAM2 is in 5 panels

1 review

Ida Ertmanska (Genomics England Curator)

Green List (high evidence)

Comment on list classification: There are more than 3 unrelated individuals reported in literature with biallelic JAM2 variants and cerebral calcification, with onset in childhood or early adulthood. Common symptoms included parkinsonism, cognitive decline, cerebellar syndrome, and dysarthria. Knockout mouse model recapitulated the human phenotype. Based on available evidence, JAM2 should be updated to Green at the next GMS update.
Created: 16 Mar 2026, 2:08 p.m. | Last Modified: 16 Mar 2026, 2:08 p.m.
Panel Version: 7.17
PMID: 31851307 Cen et al., 2020
Reported 3 unrelated families with primary familial brain calcification. Probands harboured biallelic JAM2 variants: homozygous c.140delT, p.L48Ter; homozygous c.1A>G, p.M1? and compound heterozygous mutations [c.504G>C, p.W168C & c.(67+1_68-1)_(394+1_395-1), p.Y23_V131delinsL]. The clinical phenotypes of the four patients included parkinsonism (3/4), dysarthria (3/4), seizures (1/4), and asymptomatic at the time of report (1 patient at age 37 years); disease onset ages: 20-38 years. 4/4 patients presented with severe calcifications in the cortex in addition to extensive calcifications in multiple brain areas.

PMID: 32142645 Schottlaender et al., 2023
Report of 7 individuals from 4 families with primary familial brain calcification. Detected biallelic JAM2 variants: homozygous c.685C>T, p.Arg229Ter (2 families); comp het c.395−1dupG, c.323G>A & IVS4-1dupG, p.Arg108His; homozygous c.177_180delCAGA, p.Arg60Ter.
Age of onset: childhood (3/7), teenage (2/7), 20s-30s (2/7).
Phenotype: cerebellar syndrome (6/7), Parkinsonism (5/7), dystonia (3/7), cognitive decline (5/6 assessed), brain calcification (7/7).

Functional evidence: JAM2 variants lead to reduction of JAM2 mRNA expression and absence of JAM2 protein in patient’s fibroblasts; human phenotype of brain calcification is replicated in the jam2 complete knockout mouse (jam2 KO).

JAM2 is associated with Basal ganglia calcification, idiopathic, 8, autosomal recessive, OMIM:618824 (OMIM accesed 16th Mar 2026).
Sources: Literature
Created: 16 Mar 2026, 2:06 p.m.

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Basal ganglia calcification, idiopathic, 8, autosomal recessive, OMIM:618824

Publications

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Amber
  • Literature
Phenotypes
  • Basal ganglia calcification, idiopathic, 8, autosomal recessive, OMIM:618824
Tags
Q1_26_promote_green
OMIM
606870
Clinvar variants
Variants in JAM2
Penetrance
None
Publications
Panels with this gene

History Filter Activity

16 Mar 2026, Gel status: 2

Entity classified by Genomics England curator

Ida Ertmanska (Genomics England Curator)

Gene: jam2 has been classified as Amber List (Moderate Evidence).

16 Mar 2026, Gel status: 1

Created, Added New Source, Added Tag, Set mode of inheritance, Set publications, Set Phenotypes

Ida Ertmanska (Genomics England Curator)

gene: JAM2 was added gene: JAM2 was added to White matter disorders and cerebral calcification - narrow panel. Sources: Literature Q1_26_promote_green tags were added to gene: JAM2. Mode of inheritance for gene: JAM2 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: JAM2 were set to 31851307; 32142645 Phenotypes for gene: JAM2 were set to Basal ganglia calcification, idiopathic, 8, autosomal recessive, OMIM:618824 Review for gene: JAM2 was set to GREEN